The marine compound spongistatin 1 targets pancreatic tumor progression and metastasis

International Journal of Cancer

Volumn 127, Issue 5, 2010, Pages 1096-1105

  Rothmeier, Andrea S ^a   Schneiders, Uta M ^a   Wiedmann, Romina M ^a   Ischenko, Ivan ^b   Bruns, Christiane J ^b   Rudy, Anita ^a   Zahler, Stefan ^a   Vollmar, Angelika M ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Anoikis; Bcl 2; L3.6pl cells; Marine compound; Migration

Indexed keywords

FLUOROURACIL; GELATINASE B; GEMCITABINE; PROTEIN BCL 2; SMALL INTERFERING RNA; SPONGISTATIN 1; MACROLIDE; MESSENGER RNA; TUBULIN MODULATOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANOIKIS; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CANCER GROWTH; CANCER INVASION; CANCER SURVIVAL; CELL MIGRATION; CONTROLLED STUDY; DNA FRAGMENTATION; DRUG EFFICACY; DRUG TARGETING; FEMALE; HUMAN; HUMAN CELL; IN VIVO STUDY; METASTASIS; MOUSE; NONHUMAN; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; TUMOR CELL; ZYMOGRAPHY; ANIMAL; BAGG ALBINO MOUSE; CELL ADHESION; CELL CYCLE; CELL MOTION; CELL PROLIFERATION; CLONOGENIC ASSAY; DRUG ANTAGONISM; DRUG EFFECT; DRUG SCREENING; GENETICS; LIVER TUMOR; LYMPH NODE METASTASIS; METABOLISM; NUDE MOUSE; PANCREAS TUMOR; PATHOLOGY; PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANIMALS; ANOIKIS; APOPTOSIS; BLOTTING, WESTERN; CELL ADHESION; CELL CYCLE; CELL MOVEMENT; CELL PROLIFERATION; COLONY-FORMING UNITS ASSAY; FEMALE; HUMANS; LIVER NEOPLASMS, EXPERIMENTAL; LYMPHATIC METASTASIS; MACROLIDES; MICE; MICE, INBRED BALB C; MICE, NUDE; PANCREATIC NEOPLASMS; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-BCL-2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUBULIN MODULATORS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 77955488063     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.25241     Document Type: Article

References (31)

1. Ries LAG, Krapcho M, Howlader N, Horner MJ, Mariotto A, Miller BA, Feuer EJ, Altekruse SF, Lewis DR, Clegg L, Eisner MP, Reichman M, et al. SEER cancer statistics review 1975-2005. Bethesda (MD): National Cancer Institute, 2008.
2. Deryugina EI Quigley JP. Matrix metalloproteinases and tumor metastasis. Cancer Metastasis Rev 2006;25:9-34.
3. Geho DH, Bandle RW, Clair T, Liotta LA. Physiological mechanisms of tumor-cell invasion and migration. Physiology 2005;20:194-200.
4. Fingleton B. Matrix metalloproteinases: roles in cancer and metastasis. Front Biosci 2006;11:479-91.
5. Liotta LA, Tryggvason K, Garbisa S, Hart I, Foltz CM, Shafie S. Metastatic potential correlates with enzymatic degradation of basement-membrane collagen. Nature 1980;284:67-8.
6. Bloomston M, Zervos EE, Rosemurgy AS. Matrix metalloproteinases and their role in pancreatic cancer: a review of preclinical studies and clinical trials. Ann Surg Oncol 2002;9:668-74.
7. Sahai E. Illuminating the metastatic process. Nat Rev Cancer 2007;7:737-49.
8. Mehlen P, Puisieux A. Metastasis: a question of life or death. Nat Rev Cancer 2006;6:449-58.
9. Fulda S, Debatin KM. Targeting apoptosis pathways in cancer therapy. Curr Cancer Drug Target 2004;4:569-76.
10. Igney FH, Krammer PH. Death and antideath: tumour resistance to apoptosis. Nat Rev Cancer 2002;2:277-88.
11. Pettit GR, Cichacz ZA, Gao F, Herald CL, Boyd MR, Schmidt JM, Hooper JNA. Antineoplastic agents. 257. Isolation and structure of spongistatin-1. J Org Chem 1993;58:1302-4.
12. Bai RL, Cichacz ZA, Herald CL, Pettit GR, Hamel E. Spongistatin-1, a highly cytotoxic, sponge-derived, marine natural product that inhibits mitosis, microtubule assembly, and the binding of vinblastine to tubulin. Mol Pharmacol 1993;44:757-66.
13. Catassi A, Cesario A, Arzani D, Menichini P, Alama A, Bruzzo C, Imperatori A, Rotolo N, Granone P, Russo P. Characterization of apoptosis induced by marine natural products in non small cell lung cancer A549 cells. Cell Mol Life Sci 2006;63:2377-86.
14. Schyschka L, Rudy A, Jeremias I, Barth N, Pettit GR, Vollmar AM. Spongistatin 1: a new chemosensitizing marine compound that degrades XIAP. Leukemia 2008;22:1737-45.
15. Bruns CJ, Harbison MT, Kuniyasu H, Eue I, Fidler IJ. In vivo selection and characterization of metastatic variants from human pancreatic adenocarcinoma by using orthotopic implantation in nude mice. Neoplasia 1999;1:50-62.
16. Nicoletti I, Migliorati G, Pagliacci MC, Grignani F, Riccardi C. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods 1991;139:271-9.
17. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-54.
18. Ocker M, Neureiter D, Lueders M, Zopf S, Ganslmayer M, Hahn EG, Herold C, Schuppan D. Variants of bcl-2 specific siRNA for silencing antiapoptotic bcl-2 in pancreatic cancer. Gut 2005;54:1298-308.
19. Chao DT, Linette GP, Boise LH, White LS, Thompson CB, Korsmeyer SJ. Bcl-XL and Bcl-2 repress a common pathway of cell death. J Exp Med 1995;182:821-8.
20. Haldar S, Basu A, Croce CM. Bcl2 is the guardian of microtubule integrity. Cancer Res 1997;57:229-33.
21. Mollinedo F, Gajate C. Microtubules, microtubule-interfering agents and apoptosis. Apoptosis 2003;8:413-50.
22. Franken NA, Rodermond HM, Stap J, Haveman J, van BC. Clonogenic assay of cells in vitro. Nat Protoc 2006;1:2315-19.
23. Conrad C, Ischenko I, Kohl G,Wiegand U, Guba M, Yezhelyev M, Ryan AJ, Barge A, Geissler EK,Wedge SR, Jauch KW, Bruns CJ. Antiangiogenic and antitumor activity of a novel vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor ZD6474 in a metastatic human pancreatic tumor model. Anticancer Drug 2007;18:569-79.
24. Kleespies A, Kohl G, Friedrich M, Ryan AJ, Barge A, Jauch KW, Bruns CJ. Vascular targeting in pancreatic cancer: the novel tubulin-binding agent ZD6126 reveals antitumor activity in primary and metastatic tumor models. Neoplasia 2005;7:957-66.
25. Olive KP, Jacobetz MA, Davidson CJ, Gopinathan A, McIntyre D, Honess D, Madhu B, Goldgraben MA, Caldwell ME, Allard D, Frese KK, Denicola G, et al. Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer. Science 2009;324:1457-61.
26. Klein CA. The biology and analysis of single disseminated tumour cells. Trends Cell Biol 2000;10:489-93.
27. Bold RJ, Virudachalam S, McConkey DJ. BCL2 expression correlates with metastatic potential in pancreatic cancer cell lines. Cancer 2001;92:1122-9.
28. Bhalla KN. Microtubule-targeted anticancer agents and apoptosis. Oncogene 2003;22:9075-86.
29. Martin SS, Vuori K. Regulation of Bcl-2 proteins during anoikis and amorphosis. Biochim Biophys Acta 2004;1692:145-57.
30. Pinkas J, Martin SS, Leder P. Bcl-2-mediated cell survival promotes metastasis of EpH4 betaMEKDD mammary epithelial cells. Mol Cancer Res 2004;2:551-6.
31. Wang Z, Song W, Aboukameel A, MohammadM,Wang G, Banerjee S, Kong D, Wang S, Sarkar FH, Mohammad RM. TW-37, a small-molecule inhibitor of Bcl-2, inhibits cell growth and invasion in pancreatic cancer. Int J Cancer 2008;123:958-66.